These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38710716)

  • 1. Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis.
    Heavey MK; Hazelton A; Wang Y; Garner M; Anselmo AC; Arthur JC; Nguyen J
    Nat Commun; 2024 May; 15(1):3784. PubMed ID: 38710716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Probiotic Effects of the
    Lee JE; Lee E
    J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both
    Xu X; Wu J; Jin Y; Huang K; Zhang Y; Liang Z
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-Killed
    Jin Y; Wu J; Huang K; Liang Z
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
    Liu CH; Chang JH; Chang YC; Mou KY
    J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
    Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
    J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactic Acid-Producing Probiotic
    Sun S; Xu X; Liang L; Wang X; Bai X; Zhu L; He Q; Liang H; Xin X; Wang L; Lou C; Cao X; Chen X; Li B; Wang B; Zhao J
    Front Immunol; 2021; 12():777665. PubMed ID: 34899735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Saccharomyces boulardii in a rat model of colitis.
    Soyturk M; Saygili SM; Baskin H; Sagol O; Yilmaz O; Saygili F; Akpinar H
    World J Gastroenterol; 2012 Nov; 18(44):6452-60; discussion p. 6459. PubMed ID: 23197891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice.
    Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ
    Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus rhamnosus KBL2290 Ameliorates Gut Inflammation in a Mouse Model of Dextran Sulfate Sodium-Induced Colitis.
    Kim WK; Min SG; Kwon H; Park S; Jo MJ; Ko G
    J Microbiol; 2023 Jul; 61(7):673-682. PubMed ID: 37314676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
    Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
    PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Gao H; Li Y; Sun J; Xu H; Wang M; Zuo X; Fu Q; Guo Y; Chen Z; Zhang P; Li X; Wang N; Ye T; Yao Y
    Oxid Med Cell Longev; 2021; 2021():1622375. PubMed ID: 34367460
    [No Abstract]   [Full Text] [Related]  

  • 13. Proinflammatory and anti-inflammatory cytokines present in the acute phase of experimental colitis treated with Saccharomyces boulardii.
    Grijó NN; Borra RC; Sdepanian VL
    Dig Dis Sci; 2010 Sep; 55(9):2498-504. PubMed ID: 19997974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Inflammatory, Barrier Maintenance, and Gut Microbiome Modulation Effects of
    Hu Q; Yu L; Zhai Q; Zhao J; Tian F
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.
    Mar JS; Nagalingam NA; Song Y; Onizawa M; Lee JW; Lynch SV
    Gut Microbes; 2014 Jul; 5(4):494-503. PubMed ID: 25144681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii.
    Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J
    Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-Specific Anti-inflammatory Properties of Two
    Zhai R; Xue X; Zhang L; Yang X; Zhao L; Zhang C
    Front Cell Infect Microbiol; 2019; 9():239. PubMed ID: 31334133
    [No Abstract]   [Full Text] [Related]  

  • 19. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
    Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Saccharomyces boulardii reduced intestinal inflammation in mice model of 2,4,6-trinitrobencene sulfonic acid induced colitis: based on microarray].
    Lee SK; Kim HJ; Chi SG
    Korean J Gastroenterol; 2010 Jan; 55(1):33-45. PubMed ID: 20098065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.